Clinical Trial Update: Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results for capecitabine and bevacizumab with or without atezolizumab in patients with refractory metastatic colorectal cancer; the study is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Tecentriq (atezolizumab)
• Xeloda (capecitabine)

Snippet

Sponsor: Academic and Community Cancer Research United | Conditions: Metastatic Colorectal Carcinoma, Recurrent Colorectal Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2020-02-05